News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Spectral Molecular Imaging, Inc. Releases Letter to Shareholders Outlining Proprietary Technology for Improved Diagnosis of Cancer and other Disease



6/15/2010 9:39:02 AM

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Spectral Molecular Imaging, a wholly-owned subsidiary of Cascade Technologies, Inc. (OTCBB: CSDT), has released a letter to shareholders from Chairman and founder, Daniel L. Farkas, Ph.D. In the letter, Dr. Farkas introduces the Company's proprietary technology and its plans to develop a line of next-generation medical diagnostic devices in the field of cancer and for other medical needs:

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES